Pre-distribution prognosis It’s been a tough year for humanity, but, with two COVID-19 vaccines rolling out, 2021 might look much better different. That'll all depend on how the rollouts go, but with few vaccines launching and even more being tested there is finally a cause to be optimistic about this year. In less than a year, Pfizer/BioNTech and Moderna conducted clinical testing, submitted their programs to the FDA and won emergency authorizations. The U.K. approved the Pfizer shot Dec. 2, and limited vaccinations started the following week. European regulators just this week signed off on the Pfizer shot. But winning an FDA authorization isn't the finish line. It'll be a monumental challenge for to distribute the vaccines and administer shots to hundreds of millions of people as COVID-19 continues to spread apace. Current vaccination situation Cumulative COVID-19 vaccination doses administered per 100 people, Jan 18, 2021 As of January 14, ju...